Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14
Jubilee Brown, Austin Miller, Laura L. Holman, Floor Backes, Christa Nagel, David A Bender, David S. Miller, Matthew A. Powell, Shannon N. Westin, Albert J. Bonebrake, Carolyn Y. Muller, Angeles Alvarez Secord, Erin K. Crane, John O. Schorge, William P. Tew, Anil K. Sood, Michael A. Bookman, Carol Aghajanian, David M. Gershenson
Topics & Concepts
MedicineGynecologic oncologyCarboplatinBleomycinEtoposideOncologyCisplatinInternal medicinePaclitaxelChemotherapyOvarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesPARP inhibition in cancer therapy